Sign in

CIK 0001944552 · Non-accelerated filer<br>Emerging growth company

Adlai Nortye Group Ltd.

Sign in to watch
Ticker
ANL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Singapore
Entity type
other
Phone
848-230-7430
Business address
77 ROBINSON ROAD, #20-01, ROBINSON 77, SINGAPORE, Singapore, 068896
Former names
Adlai Nortye Ltd.
  1. 424B7 Offering Prospectus
  2. 6-K Event Report of Foreign Issuer
  3. 3 Insider Initial Statement of Ownership
  4. 4 Other acquisition Director acquired 136,667 shares (other)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale CEO sold 10 shares at $13.18 ($132)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 3/A Insider 3/A
  13. 3/A Insider 3/A
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. EFFECT Other Notice of Effectiveness
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. F-3/A Offering F-3/A
  19. F-3/A Offering F-3/A
  20. 6-K Event Report of Foreign Issuer

Page 2 of 6 · 114 filings